Gene Query: RBBP8NL

Dataset Description Geneva Score
Transcriptional profiling of LS1034 cells treated with tepoxalin 9.98
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 6.65
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 6.62
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 6.44
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 5.17
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 4.97
The landscape of alternative splicing in aggressive prostate cancers 4.5
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 4.24
Silencing p300 in MCF7 cells to study expression and alternative splicing 4.17
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 3.99
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.92
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 3.64
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 3.64
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 3.57
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 3.42
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 3.32
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 3.08
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 2.62
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.57
NR2F2 study 2.35
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 2.35
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 2.3
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 2.22
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 2.22
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 2.09
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 2.06
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 1.96
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 1.95
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.93
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 1.81
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 1.79
Active translatome profiling with RiboLace in MCF7 cells 1.71
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 1.67
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 1.65
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 1.6
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 1.57
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 1.57
PTHrP overexpression in MCF7 cells 1.42
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.38
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 1.38
Genome wide expression change by RNF168 knocking down in MCF-7 cells 1.36
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.25
Energy Metabolism during Anchorage-Independence 1.18
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 1.17
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 1.16
H1609088 Human RNA-Sequencing 1.09
Patient-derived luminal breast cancer xenografts with progestins 1.08
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 1.08
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.07
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.04
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.02
snRNAs as regulators of alternative splicing 0.99
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 0.99
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.99
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 0.99
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 0.97
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 0.95
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 0.94
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 0.94
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.89
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 0.88
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 0.88
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 0.85
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 0.84
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 0.81
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 0.81
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.8
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 0.78
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 0.77
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 0.77
Dtx3L and Androgen Signaling in Prostate Cancer 0.77
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.77
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 0.76
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 0.76
Transcriptome analysis in Neobractatin treated cells 0.75
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 0.73
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 0.73
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.72
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.72
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.71
The transcriptome effect of overexpressing EZH2 in MCF7 0.71
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.7
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 0.69
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 0.68
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 0.68
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 0.67
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 0.66
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.66
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 0.65
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 0.65
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 0.65
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 0.64
MCF-7 as a model for functional analysis of breast cancer risk variants 0.64
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 0.63
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.63
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.63
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.62
BAF controls genome accessibility 0.62
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 0.62
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 0.62
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.61
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 0.6
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 0.59
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 0.59
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.59
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.58
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 0.55
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.54
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 0.54
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 0.53
Gene expression profile in breast cancer cell lines using RNA sequencing 0.52
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 0.5
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.49
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.49
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.49
Total RNA sequencing of WT intestinal orgaonids. 0.48
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 0.47
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 0.47
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 0.47
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 0.47
Cellular response to hepatitis E virus (HEV) infection 0.46
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 0.46
Expression profiling of MCF-7 cells with treatment of TCDD 0.45
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 0.45
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 0.45
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 0.45
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 0.44
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 0.44
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 0.44
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.44
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.43
Identification of global XBP1s target gene expression in human prostate cancer cells 0.43
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.43
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 0.42
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 0.42
Single-nucleotide-resolution mapping of HBV promoters using CAGE 0.41
Conservative alteration of chromosomal expression pattern across human solid tumor types 0.4
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.4
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.39
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 0.38
RNA-sequencing 0.38
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 0.38
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.38
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 0.38
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 0.37
The role of the Calcium-Sensing receptor in colorectal cancer 0.36
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 0.36
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 0.36
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 0.36
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.35
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 0.35
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.34
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.34
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.33
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.33
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 0.33
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 0.33
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 0.33
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 0.33
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.33
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 0.33
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.32
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 0.32
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.32
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 0.32
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 0.32
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 0.32
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 0.31
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.31
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 0.31
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 0.31
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 0.31
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 0.3
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 0.3
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 0.3
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 0.3
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.3
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 0.29
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 0.29
Paxillin regulates genomic networks in prostate cancer [LNCaP] 0.29
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.29
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.29
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.29
BASP1 modifies the Tamoxifen response 0.28
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 0.28
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 0.28
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 0.28
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.28
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 0.28
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 0.28
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 0.28
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.28
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.27
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 0.27
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 0.27
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 0.26
HEK293 Heat-shock experiment 0.25
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 0.24
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 0.24
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 0.24
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 0.24
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 0.24
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 0.24
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 0.23
Paxillin regulates genomic networks in prostate cancer [C4-2] 0.23
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 0.22
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 0.22
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 0.22
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 0.21
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.21
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 0.21
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 0.21
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 0.21
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 0.2
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 0.2
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.2
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.2
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 0.2
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.2
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.2
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.2
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.2
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 0.2
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 0.2
Fusion discovery in breast cancer cell line 0.19
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 0.19
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 0.19
Primary human trophoblast from term placenta 0.19
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.18
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 0.18
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 0.18
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 0.18
Genome-wide Analysis of Chromatin Interactions in Human Cells 0.18
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.18
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.18
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 0.17
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.17
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.17
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.17
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 0.17
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 0.17
RNA sequencing of human pancreatic cancer cell lines 0.17
Lipid degradation promotes prostate cancer cell survival 0.17
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 0.17
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 0.17
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 0.17
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 0.16
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 0.16
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 0.16
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 0.16
Identifying the molecular mode of action of itraconazole in colorectal cancer 0.16
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.16
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.16
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 0.15
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 0.15
Genome expression analysis of Lung Progenitors matured in the presence of constitutively active or pharmacologically inhibited Glycogen Synthase Kinase 3 0.15
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.15
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 0.15
Transcriptome analysis of virus infected tissues 0.15
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 0.15
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.15
Identification of HOXB13 target genes responsive to BET inhibitors 0.15
The conserved transcriptional landscapes in human spermatogenesis 0.15
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 0.15
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 0.15
Preclinical model of obesity and ER-positive breast cancer 0.15
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 0.15
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 0.15
FOXD3 is a novel tumor suppressor in lung cancer 0.15
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 0.15
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 0.15
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.14
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 0.14
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.14
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.14
Effect of PBK knockdown on C4-2 cell transcriptome 0.14
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 0.14
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 0.14
Total RNA sequencing of APC mutant and wt colonic organoids 0.14
A prostate cancer chromatin interaction map 0.14
RNAseq analysis of ESRP regulated splicing events in prostate cancer 0.14
Transcriptome profiling of Normal and Cancerous Prostate Cells 0.14
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.14
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 0.14
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 0.14
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 0.14
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 0.14
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.14
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.14
Differential Gene Expression between MCF10A and MCF7 cells 0.14
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 0.14
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.14
HNRNPM-regulated splicing dependencies in prostate cancer 0.14
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 0.14
RNA-seq of YB5 cells treated with Proscillaridin A 0.14
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.13
RNAseq of cell lines with knocked in ESR1 mutations 0.13
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 0.13
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.13
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 0.13
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 0.13
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 0.13
AR-independent prostate cancer is sustained through FGF signaling 0.13
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 0.13
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.13
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 0.13
HNRNPL and its RNA Targets in Prostate Cancer 0.13
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 0.13
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 0.13
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 0.13
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 0.13
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.13
UV_24h_GRO-Seq 0.12
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.12
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.12
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 0.12
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 0.12
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 0.12
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 0.12
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 0.12
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 0.12
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 0.12
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 0.12
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 0.12
iPSC-Derived Cholangiocytes 0.11
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 0.11
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 0.11
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.11
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.11
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.11
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.11
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.11
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.11
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 0.11
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.11
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.11
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 0.11
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 0.11
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.11
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 0.11
Interaction between mitoNEET and NAF-1 in cancer cells 0.11
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.11
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.11
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.11
Capturing the Interactome of Newly Transcribed RNA (RICK) 0.11
Capturing the Interactome of Newly Transcribed RNA 0.11
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.11
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.1
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.1
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.1
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.1
Gene expression analysis of human adenomas. 0.1
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.1
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 0.1
Androgen Receptor-regulated genes in prostate cancer cells 0.1
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 0.1
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.1
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.1
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 0.1
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 0.1
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 0.1
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.1
RNA-seq analysis and shRNA screen of breast cancer 0.1
RNA-seq analysis of breast cancer 0.1
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.09
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 0.09
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 0.09
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.09
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 0.09
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 0.09
Noncoding regions are the main source of targetable tumor-specific antigens 0.09
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 0.09
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.09
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.09
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 0.09
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.09
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 0.09
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 0.09
Iron response of HepG2 cells 0.09
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.09
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 0.09
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 0.09
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 0.09
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 0.08
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 0.08
Effect of nuclear IL-33 on gene expression 0.08
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 0.08
The expression profiles of GBC liver metastasis 0.08
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.08
Differential Protein Occupancy Profiling of the mRNA Transcriptome 0.08
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.08
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.08
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.08
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.08
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 0.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.08
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.08
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 0.08
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.08
Epigenome regulation during epidermal lineage commitment 0.07
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 0.07
RNA-Seq with and without RNase treatment in PCa cell lines 0.07
Endometrial transcriptome and PGR cistrome in cycling fertile women 0.07
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 0.07
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 0.07
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.07
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 0.07
RNA-seq of cancer cell lines treated with T-025 0.07
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 0.07
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 0.07
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 0.07
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.07
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.07
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.07
RNAseq of IL-36 stimulated primary human keratinocytes 0.06
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 0.06
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 0.06
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 0.06
Investigate A2M treatment on human prostate cancer and mouse liver 0.06
Investigate A2M treatment on human prostate cancer xenograft in mice 0.06
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 0.06
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.06
Genome-wide functional assessment of enhancer activities in the human genome 0.05
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.05
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.05
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.05
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 0.05
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.05
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 0.05
RNA-seq differential expression studies: more sequence, or more replication? 0.05
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 0.05
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 0.05
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 0.05
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.05
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 0.05
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.05
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 0.05
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.05
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.04
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.04
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 0.04
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.04
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.04
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.04
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.04
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.04
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.04
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.04
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.04
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.04
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.04
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 0.04
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.03
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.03
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.03
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.03
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.03
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.03
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.03
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.03
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.03
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.03
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.03
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 0.03
A practical evaluation of alignment algorithms for RNA variant calling analysis 0.03
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.02
Gene expression analysis of breast cancer cell-lines 0.02
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.02
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.02
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.02
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.02
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.02
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.02
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 0.02
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.02
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.02
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.02
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.02
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 0.02
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.02
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.02
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.02
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 0.02
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 0.02
CDK4/6 inhibitor resistance in prostate cancer 0.02
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 0.01
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.01
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.01
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.01
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.01
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.01
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.01
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.0
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.0
RNA-sequencing analysis examining how the Vibrio cholerae MARTX toxin and its inidividual effector domains modulate the transcriptome of human intestinal epithelial cells. 0.0
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.0
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.0
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation